Abo-Elmatty, Dina M <br/><br/>
Metformin enhancing the antitumor efficacy of carboplatin against Ehrlich solid carcinoma grown in diabetic mice: Effect on IGF-1 and tumoral expression of IGF-1 receptors.  [electronic resource] 

 -  International immunopharmacology  Mar 2017 
 - 72-86 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1878-1705 
<br/><br/><label>Standard No.: </label>10.1016/j.intimp.2017.01.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--therapeutic use<br/>Apoptosis--drug effects<br/>Carboplatin--therapeutic use<br/>Carcinoma, Ehrlich Tumor--complications<br/>Caspase 3--metabolism<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Diabetes Mellitus, Experimental--complications<br/>Drug Synergism<br/>Female<br/>Humans<br/>Insulin-Like Growth Factor I--metabolism<br/>Intercellular Signaling Peptides and Proteins--metabolism<br/>Metformin--therapeutic use<br/>Mice<br/>Mice, Inbred Strains<br/>Neovascularization, Pathologic--complications<br/>Receptor, IGF Type 1--metabolism<br/>Vascular Endothelial Growth Factor A--metabolism